Detailed
Compact
Art
Reverse
July 14, 2020
An interview with Dr. Charles Loprinzi from Mayo Clinic in Rochester, MN on “Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.” This update incorporates new evidence into recommendations for the prevention and treatment of chemotherapy-induced peripheral neuropathy in adults with a history of cancer. Read the full guideline at www.asco.org/survivorship-guidelines
July 13, 2020
An interview with Dr. Paul J. Hesketh from Lahey Hospital and Medical Center in Burlington, MA on “Antiemetics: ASCO Guideline Update.” This update addresses antiemetic prophylaxis in patients treated with checkpoint inhibitors and incorporates new data since the last guideline publication. Read the full guideline at www.asco.org/supportive-care-guidelines.
June 22, 2020
An interview with Dr. Manish Shah from New York Hospital Weill Cornell Medical Center on “Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.” This guideline provides evidence-based recommendations on treatment options for patients with locally advanced esophageal adenocarcinoma and squamous cell carcinoma. Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines
May 20, 2020
An interview with Dr. Eric Roeland from Massachusetts General Hospital Cancer Center on “Management of Cancer Cachexia: ASCO Guideline.” This guideline provides evidence-based recommendations on the clinical management of cancer cachexia in adult patients with advanced cancer. Recommendations are made on both pharmacologic and nutritional interventions. Read the full guideline at www.asco.org/supportive-care-guidelines
May 7, 2020
An interview with Dr. Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital on “Lung Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.” This guideline provides recommendations to clinicians on radiographic imaging and biomarker surveillance strategies after definitive curative-intent therapy in patients with stage I-III non–small-cell lung cancer and small-cell lung cancer. Read the full guideline at www.asco.org/thoracic-cancer-guidelines
April 23, 2020
An interview with Dr. Jessica Geiger from Cleveland Clinic on “Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline.” This guideline provides evidence-based recommendations addressing diagnosis, surgery, radiation therapy, and systemic therapy for patients with squamous cell carcinoma of unknown primary in the head and neck. Read the full guideline at www.asco.org/head-neck-cancer-guidelines
April 3, 2020
An interview with Dr. Nadine Tung from Beth Israel Deaconess Medical Center in Boston, MA on “Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline.” This guideline covers recommendations for the management of patients with breast cancer with germline mutations in breast cancer susceptibility genes. Read the full guideline at www.asco.org/breast-cancer-guidelines
March 31, 2020
An interview with Dr. Pauline Funchain from Cleveland Clinic in Cleveland, OH on "Systemic Therapy for Melanoma: ASCO Guideline." This guideline provides recommendations on systemic therapy options for adult patients with cutaneous and noncutaneous melanoma. Read the full guideline at www.asco.org/melanoma-guidelines
March 9, 2020
An interview with Dr. Gabriela Chiorean from the University of Washington, Fred Hutchinson Cancer Research Center, Dr. Mary Chamberlin from Dartmouth-Hitchcock Medical Center, and Dr. Pritesh Lohar from the HCG Cancer Center, on “Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline.” This guideline provides guidance for resource-constrained settings on the management of late-stage CRC. Read the full guideline at www.asco.org/resource-stratified-guideli
February 14, 2020
An interview with Dr. Sharon Giordano from MD Anderson Cancer Center and Dr. Michael Hassett from Dana-Farber Cancer Institute on "Management of Male Breast Cancer: ASCO Guideline". This guideline provides recommendations for the management of male breast cancer; addressing areas where treatment for men differs from the approach used for women. Read the full guideline at www.asco.org/breast-cancer-guidelines.
January 28, 2020
An interview with Dr. Nasser Hanna from Indiana University and Dr. Gregory Masters from Helen F. Graham Cancer Center and Research Institute on "Therapy for Stage IV NSCLC Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update." This guideline provides recommendations on treatment options for patients with stage IV NSCLC without driver alterations based on histology, PD-L1 status, and/or contraindications. Read the full guideline at www.asco.org/thoracic-cancer-guidelines.
January 28, 2020
An interview with Dr. Philip Saylor from Massachusetts General Hospital on "Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline." This guideline includes recommendations for management of osteoporotic fracture risk in nonmetastatic disease and interventions for men with castration-resistant prostate cancer metastatic to bone. Read the full guideline at www.asco.org/genitourinary-cancer-guidelines.
January 27, 2020
An interview with Dr. Christina Annunziata from the National Cancer Institute on "Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline". This guideline provides recommendations for women diagnosed with epithelial ovarian cancer and their families on which individuals should receive risk evaluation, counseling, and genomic testing, and when they should be tested. Read the full guideline at www.asco.org/gynecologic-cancer-guidelines.
January 15, 2020
An interview with Dr. Edouard Trabulsi from the Sidney Kimmel Medical College at Thomas Jefferson University on "Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline." This guideline outlines techniques available and provides recommendations on appropriate use of imaging for specified patient subgroups. Read the full guideline at www.asco.org/genitourinary-cancer-guidelines.
January 13, 2020
An interview with Dr. Kimberly Allison from Stanford University School of Medicine and Dr. Antonio Wolff from Johns Hopkins University on "Estrogen and Progesterone Receptor Testing in Breast Cancer Guideline: ASCO/CAP Guideline Update." This guideline updates the ASCO/CAP estrogen and progesterone receptor testing in breast cancer guideline, and focuses on low estrogen receptor expression cases. Read the full guideline at www.asco.org/breast-cancer-guidelines.
December 12, 2019
An interview with Dr. Scott Eggener of University of Chicago Medicine on "Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline." This guideline provides recommendations for available tissue-based prostate cancer biomarkers geared toward patient selection for active surveillance, identification of clinically significant disease, choice of postprostatectomy adjuvant versus salvage radiotherapy, and to address emerging questions such as the relative value of tissue biomarkers compared with MRI.
December 9, 2019
An interview with Dr. Melissa Dillmon on the Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. The interview covers the findings of the systematic review, which were consistent with the NCODA patient-centered standards for patient relationships and education, adherence, safety, collection of data, documentation and other areas. NCODA standards were adopted and used as basis for these ASCO/NCODA standards. Additional information is available at www.asco.org/mid-standards.
September 18, 2019
An interview with Dr. Charles Shapiro from Mount Sinai Hospital in New York and Dr. Joan Neuner from Medical College of Wisconsin, co-chairs of "Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease: ASCO Clinical Practice Guideline." This guideline includes recommendations on assessing risk factors and interventions, including pharmacologic and nonpharmacologic options. Read the full guideline at www.asco.org/survivorship-guidelines
September 3, 2019
An interview with Dr. Kala Visvanathan from Sidney Kimmel Comprehensive Cancer Center, and Johns Hopkins Bloomberg School of Public Health on the guideline update. This update adds anastrozole to the options of pharmacologic interventions for breast cancer risk reduction based on recent practice changing data. Read the full guideline at www.asco.org/breast-cancer-guidelines.
August 5, 2019
An interview with Dr. Anna Falanga on "Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice Guideline Update." The guideline revises several previous recommendations. Most notably, direct oral anticoagulants (DOACs) have been added as options for VTE prophylaxis and treatment. Read the full guideline at www.asco.org/supportive-care-guidelines Find all of ASCO's podcasts at podcast.asco.org
July 22, 2019
An interview with Dr. Noam Yarom, Dr. Charles Shapiro, Dr. Deborah Saunders and Dr. Doug Peterson on "Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline." This guideline addresses the prevention and management of MRONJ in patients with cancer. Read the full guideline at www.asco.org/supportive-care-guidelines Find all of the ASCO podcasts at podcast.asco.org
June 17, 2019
An interview with Dr. Lynn Henry from University of Utah Huntsman Cancer Institute on "Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of CCO Guideline." This guideline update includes data from the MINDACT and TAILORx trials to clarify the recommendations for patients with hormone receptor-positive, HER2 not overexpressed, axillary node-negative early breast cancer.
June 10, 2019
An interview with Dr. AloK Khorana from Cleveland Clinic on "Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update." This guideline update adds another treatment regimen to the options for patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy.  Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines  See all of ASCO's podcasts at www.asco.org/podcasts
May 31, 2019
An interview with Dr. Fabrice Andre from Institute Gustave Roussy, Paris Sud University, in Paris, France on Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update: Integration of Results from TAILORx. This update provides updated recommendations on chemoendocrine therapy for patients who present with a hormone receptor positive, HER2 not overexpressed, axillary node negative early breast cancer.
April 25, 2019
An interview with Dr. David Adelstein of the Cleveland Clinic on the ASCO PCO which provides statements on the role of treatment deintensification in the management of p16+ oropharyngeal cancer. Read the full PCO at www.asco.org/head-neck-cancer-guidelines
April 15, 2019
An intervew with Dr. Nancy Baxter on "Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline." The guideline makes recommendations based on the results of the IDEA collaboration. Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines
April 10, 2019
An interview with Dr. Alejandro Lazo-Langner on Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update which provides recommendations on ESAs (and biosimilars) for patients with chemotherapy-associated anemia in the noncurative setting.
April 1, 2019
An interview with Dr. Joe Mikhael from the City of Hope Cancer Center and International Myeloma Foundation on the ASCO and CCO joint clinical practice guideline. The guideline makes recommendations for patients who are transplantation eligible and ineligible with relapsed or refractory disease.
March 18, 2019
An interview with Dr. Susan Chang from the University of California San Francisco on the ASCO and SNO Endorsement of the CNS Guidelines. Read the full guideline at www.asco.org/neurooncology-guidelines
March 11, 2019
An interview with Dr. Rachna Shroff from the University of Arizona Cancer Center on the guideline which provides recommendations on the role of post-operative therapy in patients who undergo surgical resection for biliary tract cancers. Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines
February 27, 2019
An interview with Dr. Shlomo Koyfman of the Cleveland Clinic on "Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline" which provides recommendations on topics such as neck dissections and postoperative treatment.
February 25, 2019
An interview with Dr. Manish Shah from New York Presbyterian Weill Cornell Medical Center on the ASCO Resource Stratified Guideline which covers treatment of patients with early-stage colorectal cancer. To read the full guideline go to www.asco.org/resource-stratified-guidelines
January 8, 2019
An interview with Dr. Paul Celano from the Greater Baltimore Medical Center on the recently published ASCO Standards on safe handling of hazardous drugs.
December 3, 2018
An interview with Dr. Valerie de Haas from Princess Máxima Center for Pediatric Oncology in the Netherlands on "Initial Diagnostic Workup of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the CAP and ASH Guideline.” ASCO fully endorses the CAP-ASH guideline on initial diagnostic work-up of AL and includes some discussion points according to clinical practice and updated literature.
November 20, 2018
An interview with Dr. Elena Stoffel from University of Michigan on Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. This PCO addresses identification and management of patients and family members with possible predisposition to pancreatic adenocarcinoma.
November 19, 2018
An interview with Dr. Jennifer Griggs from University of MIchigan on Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. This guideline provides recommendations on extended adjuvant therapy. on particular, use of aromatase inhibitors in women who had completed five years of adjuvant endocrine therapy.
October 11, 2018
An interview with Dr. Scott Morgan from the Ottawa Hospital and University of Ottawa on "Hypofractionated Radiation Therapy for Localized Prostate Cancer: an ASTRO, ASCO, and AUA Evidence-Based Guideline.” This guideline provides recommendations on hypofractionated external beam radiation therapy for localized prostate cancer.
September 6, 2018
An interview with Dr. Carole Fakhry from Johns Hopkins School of Medicine on the ASCO endorsement of the CAP guideline on human papillomavirus (HPV) testing in head and neck carcinomas. Read the full guideline at www.asco.org/head-neck-cancer-guidelines
September 5, 2018
An interview with Dr. Justin Bekelman from University of Pennsylvania Perelman School of Medicine on the ASCO endorsement of the AUA/ASTRO/SUO Guideline on the management of localized prostate cancer. Read the full guideline at www.asco.org/genitourinary-cancer-guidelines
September 4, 2018
An interview with Dr. Randy Taplitz from UC San Diego Health on the guideline update which addresses antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. Read the full guideline at www.asco.org/supportive-care-guidelines
June 25, 2018
An interview with Dr. Naren Ramakrishna from University of Florida Health Cancer Center at Orlando Health on the guideline update which addresses management of brain metastases for patients with human epidermal growth factor receptor 2–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines
June 25, 2018
An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines
June 11, 2018
An interview with Dr. Gary Lyman from Fred Hutchinson Cancer Research Center and University of Washington and Dr. Lorenzo Cohen from the University of Texas MD Anderson Cancer Center on the ASCO endorsement of the SIO guideline on use of integrative therapies during and after breast cancer treatment. The guideline addresses the use of integrative therapies for the management of symptoms and adverse effects. Read the full guideline at www.asco.org/supportive-care-guidelines.
June 5, 2018
An interview with Dr. Hedy Kindler of the University of Chicago on the guideline which includes recommendations on diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy, and multimodality therapy in patients with malignant pleural mesothelioma. Read the full guideline at www.asco.org/thoracic-cancer-guidelines
May 30, 2018
An interview with Dr. Antonio Wolff from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center on the ASCO/CAP guideline update which addresses IHC and ISH testing for HER2 in breast cancer.  Read the full guideline at www.asco.org/breast-cancer-guidelines
May 23, 2018
An interview with Dr. Davendra Sohal from the Cleveland Clinic on the guideline update regarding second-line therapy for patients with metastatic pancreatic cancer. Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines
May 22, 2018
An interview with Dr. Neelima Denduluri from US Oncology, Virginia Cancer Specialists, on the key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer. Read the full guideline on www.asco.org/breast-cancer-guidelines
May 21, 2018
An interview with Dr. Supriya Mohile from University of Rochester on the guideline published in JCO which provides guidance regarding the practical assessment and management of vulnerabilities in older patients undergoing chemotherapy.  To read the full guideline go to www.asco.org/supportive-care-guidelines.
May 14, 2018
An interview with Dr. Neelima Denduluri, Dr. Manish Shah, Dr. Mariana Chavez Mac Gregor, and Tom Oliver discussing the ASCO Clinical Practice Guidelines program, methodology, panel representation, and vision for the future. Read more at www.asco.org/guidelines
May 8, 2018
Interview with Dr. Nahla Gafer from Radiation & Isotope Center in Sudan. Purpose of this guideline is to provide guidance to clinicians and policymakers on implementing palliative care in resource-constrained settings and to complement the 2016 ASCO Palliative Care Guideline. ASCO's view is that healthcare providers and healthcare system decision makers should be guided by the recommendations for the highest stratum of resources available. Guideline is intended to complement, not replace local guidelines.
May 4, 2018
An interview with Dr. Paul Hesketh from Lahey Hospital and Medical Center on the antiemetics guideline update published in 2017. The guideline update expands the recommendations to include olanzapine and neurokinin 1 receptor antagonists. Read the full guideline at www.asco.org/supportive-care-guidelines
April 27, 2018
An interview with Dr. Timothy Gilligan from Taussig Cancer Institute and Institute and the Center for Excellence in Healthcare Communication, Cleveland Clinic, Cleveland, OH on the guideline providing guidance to oncology clinicians on how to use effective communication to optimize the patient-clinician relationship, patient and clinician well-being, and family well-being. Read the full guideline at www.asco.org/supportive-care-guidelines
April 18, 2018
An interview with Dr. Betty R. Ferrell of City of Hope Medical Center on the guideline which provides evidence-based recommendations to oncology clinicians, patients, family and friend caregivers, and palliative care specialists on the integration of palliative care into standard oncology care for all patients diagnosed with cancer.  A guideline on palliative care in the global setting is currently in press. Read the full guideline at www.asco.org/supportive-care-guidelines
April 5, 2018
An interview with Dr. Alison W. Loren of Perelman School of Medicine of the University of Pennsylvania on the ASCO guideline update which provides current recommendations about fertility preservation for adults and children with cancer.
April 2, 2018
An interview with Dr. Michael J. Morris from Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine on the ASCO clinical practice guideline which addresses abiraterone or docetaxel with androgen-deprivation therapy (ADT) for metastatic prostate cancer that has not been treated (or has been minimally treated) with testosterone-lowering agents.
February 20, 2018
An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer.
February 14, 2018
An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy.
Loading earlier episodes...
    15
    15
      0:00:00 / 0:00:00